Form 8-K - Current report:
SEC Accession No. 0001193125-23-067583
Filing Date
2023-03-10
Accepted
2023-03-10 16:06:02
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d434317d8k.htm   iXBRL 8-K 21985
  Complete submission text file 0001193125-23-067583.txt   146777

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA svra-20230310.xsd EX-101.SCH 2865
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20230310_lab.xml EX-101.LAB 18757
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20230310_pre.xml EX-101.PRE 11720
6 EXTRACTED XBRL INSTANCE DOCUMENT d434317d8k_htm.xml XML 3510
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 23723631
SIC: 2834 Pharmaceutical Preparations